Table 3 Immune-protective effects of recombinant cystatin
From: Preliminary molecular characterization of the human pathogen Angiostrongylus cantonensis
Group | Number of mice | Cystatin immunization | Number of surviving mice (21 days) | Average number of larvae recovered (x ± SD) | Reduction in number of larvae |
|---|---|---|---|---|---|
A | 20 | No (negative control) | 8 | 27.7 ± 8.45 | / |
B | 20 | Yes | 18 | 13.2 ± 4.52* | 52.3% |